These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18831408)

  • 21. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal impedance-pH monitoring.
    Sifrim D; Fornari F
    Dig Liver Dis; 2008 Mar; 40(3):161-6. PubMed ID: 18082474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A balancing view: Impedance-pH testing in gerd-limited role for now, perhaps more helpful in the future.
    Shay S
    Am J Gastroenterol; 2009 Nov; 104(11):2669-70. PubMed ID: 19888232
    [No Abstract]   [Full Text] [Related]  

  • 25. Pro: Impedance testing is useful in the management of GERD.
    Blondeau K; Tack J
    Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical importance of impedance measurements.
    Agrawal A; Castell DO
    J Clin Gastroenterol; 2008; 42(5):579-83. PubMed ID: 18364586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
    Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
    Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical presentations of gastroesophageal reflux disease.
    Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
    Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combined pH measurement and multiple impedance variation assessments--validation of a new technique for detection of non-acid reflux in the esophagus].
    Dreuw B; Fass J; Büchin P; Silny J; Rau G; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1143-5. PubMed ID: 9931817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reflux monitoring: on or off therapy?
    Vaezi MF
    Am J Gastroenterol; 2011 Feb; 106(2):183-5. PubMed ID: 21301447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in gastroesophageal reflux disease diagnosis and therapy.
    Ali T; Miner PB
    Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
    Waśko-Czopnik D; Błoński W; Paradowski L
    Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will esophageal impedance replace pH monitoring?
    Vandenplas Y; Salvatore S; Vieira MC; Hauser B
    Pediatrics; 2007 Jan; 119(1):118-22. PubMed ID: 17200278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
    Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
    Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study.
    Misra S
    J Gastroenterol Hepatol; 2010 Apr; 25(4):817-22. PubMed ID: 20492340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.